Sort
50,496 grants matching “lung cancer”
Shanghai Men's Health Study
$958,253Xiao-Ou Shu · Vanderbilt University Medical Center · UM1 · FY2017 · CA
Red Cell Biology
$957,817David M. Bodine · National Human Genome Research Institute · ZIA · FY2018 · HG
Novel approaches to improve prediction of cancer-associated thrombosis
$957,703Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · HL
Using Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing for all Americans who use ASL: A Randomized Controlled Trial Study
$957,649Poorna Kushalnagar · Gallaudet University · U01 · FY2025 · DC
Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network: Clinical Trials Development & Member Site Core
$957,648Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2023 · CA
A Handheld Microchip for GC analysis of breath to screen for COVID-19
$957,641Xiao-An Fu · University Of Louisville · U18 · FY2022 · TR
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$957,460Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Determining the Fate of Transmembrane Proteins
$957,415Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Genetic Epidemiology of Cancer
$957,336Joan E. Bailey-Wilson · Human Genome Research · Z01 · FY2007 · HG
Cell and Cancer Biology Branch Confocal Microscopy Core
$957,040Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Epidemiology of the four most frequent cancers following breast cancer
$956,771Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Optimizing Implementation in Cancer Control: OPTICC
$956,666Bryan J. Weiner · University Of Washington · P50 · FY2020 · CA
A kit based PET agent: edotreotide Ga 68 for clinical imaging of somatostatin rec
$956,175James F Kronauge · Invicro, Llc · R44 · FY2014 · CA
Suppressors of kRAS Activity Discovered Using a Fruit Fly-based In-vivo Screen
$956,150William A. Garland · Tosk, Inc. · R44 · FY2018 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$955,710Laura D Attardi · Stanford University · R35 · FY2022 · CA
Mechanisms governing metastatic dormancy and reactivation
$955,499Filippo G Giancotti · Columbia University Health Sciences · R35 · FY2022 · CA
Dayton Clinical Oncology Program
$955,207Howard M Gross · Dayton Clinical Oncology Program · U10 · FY2008 · CA
Cancer Risk Reduction and Diet: A Cohort Study of Women
$955,125Wei Zheng · Vanderbilt University · R37 · FY2009 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$954,936Xihong Lin · Harvard School Of Public Health · R35 · FY2016 · CA
Enhancing Primary Care Capacity for Cancer Survivorship Care Delivery in Community Health Clinics
$954,481Bijal A. Balasubramanian · University Of Texas Hlth Sci Ctr Houston · U01 · FY2025 · CA
Tumor Microenvironment in Cancer Progression
$954,297Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Cancer Risk Reduction and Diet: A Cohort Study of Women
$954,118Wei Zheng · Vanderbilt University · R01 · FY2007 · CA
Transgenic Models for Prostate and Breast Cancer
$954,020Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
UTILIZATION OF RADIOGENOMICS TO IDENTIFY TARGETABLE MET ALTERATIONS FOR LUNG CANCER BRAIN METASTASIS
$954,000University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2022 · Defense Health Agency
Biospecimen procurement and tissue microarray manufacture for the CHTN
$953,928Christopher A. Moskaluk · University Of Virginia · UM1 · FY2021 · CA